Ophthalmic plastic and reconstructive surgery۲۰۲۴۱۱ استنادنمایه شده در PubMed
Shoaib Ugradar, Emanuil Parunakian, Erin Zimmerman, Emil Malkhasyan, Pershanjit Raika, Raymond N Douglas, Andrea L Kossler, Raymond S Douglas
چکیده
Teprotumumab, a novel human monoclonal antibody, has been shown to reverse the clinical manifestations of thyroid eye disease. Previous reports have suggested that it demonstrates disease-modifying properties through the reduction of orbital fat and muscle volumes. This study aims to analyze…
متن کامل چکیده در سایت ناشر در دسترس است.
DOI: 10.1097/iop.0000000000002867